Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025
상품코드:1760697
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
중합효소 연쇄 반응(PCR) 분자진단 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 8.7%의 연평균 성장률(CAGR)로 136억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 암 발병률 증가, 맞춤형 의료에 대한 수요 증가, 분자진단학에 대한 투자 증가, 신속 진단 검사에 대한 수요 증가, 비침습적 산전 검사에 대한 수요 확대 등에 기인할 것으로 보입니다. 이 기간 동안 예상되는 주요 동향으로는 진단 기술의 발전, Point-of-Care 중합효소 연쇄 반응 시스템의 개발, 다중 중합효소 연쇄 반응의 혁신, 중합효소 연쇄 반응과 미세유체공학의 통합, 디지털 중합효소 연쇄 반응 플랫폼의 기술 강화 등을 들 수 있습니다.
전염병의 증가는 중합효소 연쇄 반응(PCR) 분자진단 시장의 확대를 촉진할 것으로 예상됩니다. 감염성 질환은 박테리아, 바이러스, 곰팡이, 기생충과 같은 유해한 미생물에 의해 발생하며, 사람에서 사람으로 직접 또는 간접적으로 전파될 수 있습니다. 이러한 질병의 확산은 항생제 내성 병원체의 증가가 주요 원인으로, 치료와 통제가 더 어려워지고, 질병의 장기화, 의료비 증가, 공중 보건 위험 증가로 이어집니다. 감염증의 관리를 개선하고, 조기 진단과 표적 치료를 가능하게 합니다. 이를 통해 적시에 개입을 촉진하고, 감염 확산을 억제하고, 환자 치료를 개선함으로써 의료 성과를 향상시킬 수 있습니다. 예를 들어, 2023년 11월 미국 보건복지부(Department of Health and Human Services)는 2022년에 새로 보고된 만성 B형 간염 환자가 2021년에 비해 11% 증가했다고 보고했습니다. 그 결과, 감염성 질환의 증가는 PCR 분자진단 시장의 성장을 촉진하고 있습니다.
중합효소 연쇄 반응(PCR) 분자진단 시장의 주요 업체들은 검사 효율성과 접근성을 향상시키기 위해 벤치탑 장비와 같은 최첨단 솔루션 개발에 주력하고 있습니다. 벤치탑형 장비는 작업대나 테이블에 놓을 수 있을 정도로 작은 실험실용 장비로, 과학, 의료, 산업용 검사 및 분석용으로 설계되어 있습니다. 예를 들어, 2024년 9월 독일에 본사를 둔 생명공학 기업 QIAGEN N.V.는 임상 종양학 검사를 위한 QIAcuityDx Digital PCR System을 발표했습니다. 이 시스템은 파티셔닝, 써모사이클, 이미징을 하나의 장비에 통합하고, 완전 자동화된 워크어웨이 프로세스가 특징이며, DNA와 RNA의 절대 정량을 약 2시간 만에 최소의 조작 시간으로 수행할 수 있습니다. 이 시스템은 멀티플렉싱 및 연속적인 나노플레이트 로딩을 위해 최대 5개의 검출 채널을 지원하며, 검증된 연구 모드와 유연한 연구 모드를 모두 제공하여 다양한 임상 및 실험실 요구사항에 적응할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 중합효소 연쇄 반응(PCR) 분자진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 성장률 분석
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 실적 : 규모와 성장, 2019-2024
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 중합효소 연쇄 반응(PCR) 분자진단 전체 시장(TAM)
제6장 시장 세분화
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기기
시약 및 소모품
소프트웨어
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
실시간 중합효소 연쇄 반응
디지털 중합효소 연쇄 반응
기존 중합효소 연쇄 반응
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 샘플 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
혈액 샘플
타액 샘플
조직 샘플
소변 샘플
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
감염증 검사
종양학 검사
기타 용도
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
진단 검사실
기타 최종사용자
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장, 기기, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
표준적 중합효소 연쇄 반응 시스템
디지털 중합효소 연쇄 반응 시스템
실시간 중합효소 연쇄 반응 시스템
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장, 시약 및 소모품, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응 키트
중합효소 연쇄 반응 효소
중합효소 연쇄 반응 프라이머와 프로브
중합효소 연쇄 반응 마스터 믹스
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장, 소프트웨어, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응 분석 소프트웨어
데이터 관리 소프트웨어
제7장 지역별·국가별 분석
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 중합효소 연쇄 반응(PCR) 분자진단 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
중합효소 연쇄 반응(PCR) 분자진단 시장 : 경쟁 구도
중합효소 연쇄 반응(PCR) 분자진단 시장 : 기업 개요
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Laboratory Corporation of America Holdings
Agilent Technologies Inc.
Grifols S.A.
Illumina Inc.
Endress+Hauser AG
bioMereieux SA
Sysmex Corporation
Bio-Rad Laboratories Inc.
QuidelOrtho Corporation
PerkinElmer
Eppendorf AG
Tecan Group
Takara Bio Inc.
Biocartis NV
Zymo Research Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
중합효소 연쇄 반응(PCR) 분자진단 시장 2029 : 새로운 기회를 제공하는 국가
중합효소 연쇄 반응(PCR) 분자진단 시장 2029 : 새로운 기회를 제공하는 부문
중합효소 연쇄 반응(PCR) 분자진단 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Polymerase chain reaction (PCR) molecular diagnostics is a laboratory method used to amplify and examine specific sequences of deoxyribonucleic acid or ribonucleic acid in a sample. Its primary function is to detect the presence of targeted genetic material, allowing for the identification of pathogens, genetic conditions, or mutations. This technique is extensively utilized in medical diagnostics due to its high sensitivity and accuracy in detecting infectious diseases, genetic disorders, and cancer-related markers.
The key product categories in PCR molecular diagnostics include instruments, reagents and consumables, and software. Instruments are devices or tools specifically designed for performing scientific, medical, or technical tasks and measurements. The technology includes real-time PCR, digital PCR, and conventional PCR methods, applied to various sample types such as blood, saliva, tissue, and urine. PCR molecular diagnostics are used across different applications, including infectious disease testing and oncology testing, and serve a range of end-users such as hospitals, diagnostic laboratories, and other healthcare facilities.
The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction molecular diagnostics market statistics, including the polymerase chain reaction molecular diagnostics industry's global market size, regional shares, competitors with the polymerase chain reaction molecular diagnostics market share, detailed polymerase chain reaction molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. This polymerase chain reaction molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth during the historic period can be attributed to the rising demand for early disease detection, a growing prevalence of infectious diseases, heightened awareness of genetic disorders, increased adoption of point-of-care testing, and a higher incidence of chronic illnesses.
The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.64 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing prevalence of cancer, rising demand for personalized medicine, growing investments in molecular diagnostics, increasing need for rapid diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends expected during this period include advancements in diagnostic technologies, development of point-of-care polymerase chain reaction systems, innovations in multiplex polymerase chain reaction, integration of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.
The growing prevalence of infectious diseases is expected to drive the expansion of the polymerase chain reaction (PCR) molecular diagnostics market. Infectious diseases are caused by harmful microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly from person to person. The increasing prevalence of these diseases is largely due to the rise of antibiotic-resistant pathogens, which are more difficult to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. PCR molecular diagnostics improve the management of infectious diseases by offering rapid and accurate pathogen detection at the genetic level, enabling early diagnosis and targeted treatment. This enhances healthcare outcomes by promoting timely interventions, reducing the spread of infections, and improving patient care. For example, in November 2023, the Department of Health and Human Services, a U.S. government agency, reported an 11% increase in newly reported chronic hepatitis B cases in 2022 compared to 2021. As a result, the rising prevalence of infectious diseases is fueling the growth of the PCR molecular diagnostics market.
Leading companies in the polymerase chain reaction (PCR) molecular diagnostics market are focusing on developing cutting-edge solutions, such as benchtop instruments, to improve testing efficiency and accessibility. Benchtop instruments are compact, laboratory-grade devices small enough to fit on a workbench or table, designed for scientific, medical, or industrial testing and analysis. For example, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, introduced the QIAcuityDx Digital PCR System for clinical oncology testing. This system features fully automated, walk-away processing, integrating partitioning, thermocycling, and imaging into a single instrument. It provides absolute quantification of DNA and RNA in about two hours, with minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading, offering both validated and flexible research modes, making it adaptable to various clinical and laboratory requirements.
In May 2024, Bruker Corporation, a U.S.-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. This acquisition allows Bruker to enhance its presence in infectious disease diagnostics by broadening its molecular diagnostic capabilities and product portfolio, enabling it to better serve clinical laboratories and hospitals worldwide. ELITech Group SAS is an Italy-based in-vitro diagnostics company, specializing in polymerase chain reaction (PCR) molecular diagnostics.
Major players in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, and Zymo Research Corporation.
North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polymerase chain reaction molecular diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the polymerase chain reaction molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on polymerase chain reaction molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for polymerase chain reaction molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction molecular diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Instrument; Reagents And Consumables; Software
2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
3. Polymerase Chain Reaction Molecular Diagnostics Market Trends And Strategies
4. Polymerase Chain Reaction Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Polymerase Chain Reaction Molecular Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Polymerase Chain Reaction Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instrument
Reagents And Consumables
Software
6.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time Polymerase Chain Reaction
Digital Polymerase Chain Reaction
Conventional Polymerase Chain Reaction
6.3. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Samples
Saliva Samples
Tissue Samples
Urine Samples
6.4. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease Testing
Oncology Testing
Other Applications
6.5. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Other End Users
6.6. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Polymerase Chain Reaction Systems
Digital Polymerase Chain Reaction Systems
Real-Time Polymerase Chain Reaction Systems
6.7. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction Kits
Polymerase Chain Reaction Enzymes
Polymerase Chain Reaction Primers And Probes
Polymerase Chain Reaction Master Mix
6.8. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction Analysis Software
Data Management Software
7. Polymerase Chain Reaction Molecular Diagnostics Market Regional And Country Analysis
7.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Polymerase Chain Reaction Molecular Diagnostics Market
9.1. China Polymerase Chain Reaction Molecular Diagnostics Market Overview
9.2. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Polymerase Chain Reaction Molecular Diagnostics Market
10.1. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Polymerase Chain Reaction Molecular Diagnostics Market
11.1. Japan Polymerase Chain Reaction Molecular Diagnostics Market Overview
11.2. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Polymerase Chain Reaction Molecular Diagnostics Market
12.1. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market
13.1. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Polymerase Chain Reaction Molecular Diagnostics Market
14.1. South Korea Polymerase Chain Reaction Molecular Diagnostics Market Overview
14.2. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market
15.1. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
15.2. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Polymerase Chain Reaction Molecular Diagnostics Market
16.1. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market
21.1. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview
21.2. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Polymerase Chain Reaction Molecular Diagnostics Market
22.1. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Polymerase Chain Reaction Molecular Diagnostics Market
23.1. North America Polymerase Chain Reaction Molecular Diagnostics Market Overview
23.2. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Polymerase Chain Reaction Molecular Diagnostics Market
24.1. USA Polymerase Chain Reaction Molecular Diagnostics Market Overview
24.2. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Polymerase Chain Reaction Molecular Diagnostics Market
26.1. South America Polymerase Chain Reaction Molecular Diagnostics Market Overview
26.2. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Polymerase Chain Reaction Molecular Diagnostics Market
27.1. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Polymerase Chain Reaction Molecular Diagnostics Market
28.1. Middle East Polymerase Chain Reaction Molecular Diagnostics Market Overview
28.2. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Polymerase Chain Reaction Molecular Diagnostics Market
29.1. Africa Polymerase Chain Reaction Molecular Diagnostics Market Overview
29.2. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape And Company Profiles
